Skip to content

To study the signal pathways of Rheumatoid Arthritis Syndrome of Accumulated Dampness and intervention mechanism of Sanhuang Yilong Decoction based the theory that lung, spleen and kidney regulate water

To study the signal pathways of Rheumatoid Arthritis Syndrome of Accumulated Dampness and intervention mechanism of Sanhuang Yilong Decoction based the theory that lung, spleen and kidney regulate water metabolism

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004520
Enrollment
Unknown
Registered
2014-04-13
Start date
2014-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

Interventions

two:Methotrexate, hydroxychloroquine sulfate pills and NSAIDs in both groups
"Sanhuang Yinong decoction" will be give in the experimental group
RA patients:NA

Sponsors

General Hospital of Chengdu Military Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Patients are in accordance with diagnosis standards of RA at active stage as well as syndrome differentiation standard of TCM pa disease (lame impediment, hot and dampness accumulation); (2) patients are informed and agreed with the research and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Age 65 years; (2) Women with pregnancy or in lactation, patients with allergic constitution; (3) Other autoimmune disease; (4) patients with serious heart, brain, liver, kidney, blood, endocrine system and gastrointestinal disease; (5) Patients with conscious disorder or unusual spirit; (6) Patients participated in other clinical trials within 3 months; (7) For other reasons, the researchers think that the patients should not be included.

Design outcomes

Primary

MeasureTime frame
AQP;STAT transcription factor;

Countries

China

Contacts

Public ContactLiu Defang
liudefang199@163.com+86 028-86571107

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026